In this podcast, we speak with 2 experts to discuss results from Performance Period 2, and get insight into the successes, challenges, and lessons learned under the Oncology Care Model (OCM), thus far.
Practices participating in the Oncology Care Model now have results back from 2 performance periods and are enrolling in performance period 6. With more than 2 years of experience under the model, some practices have found success while others struggle to improve. And with considerable lag time between the end of a performance period and the release of the full report, practices find themselves struggling to quickly pinpoint areas of improvement.
In this podcast, we speak with 2 experts to discuss results from Performance Period 2, and get insight into the successes, challenges, and lessons learned under the OCM, thus far.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss?rel=0"
TuneIn: http://bit.ly/2gv7iwj?rel=0"
Stitcher: http://bit.ly/2gCqtFg?rel=0"
Read more about OCM performance:
OCM Performance Period One Initial Reconciliation
Cautious Optimism: OCM Participants Seem to Have Improved in Performance Period 2
Feedback on the Direction, Challenges of the OCM
Implications of OCM Reports and the Future of the Program
Delay in Performance Period Results Challenges Practices Participating in OCM
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen